Quidel Picks Up Diagnostic Hybrids For $130M
Diagnostic test maker Quidel Corp. has revealed plans to shell out $130 million in cash to snap up Diagnostic Hybrids Inc., which manufactures direct fluorescent in vitro diagnostic assays, a move...To view the full article, register now.
Already a subscriber? Click here to view full article